Evidence map›Paper›PMID 30192816›Full record

ArticlePloS one2018

Timing of adverse events among voluntary medical male circumcision clients: Implications from routine service delivery in Zimbabwe.

Caryl Feldacker, Aaron F Bochner, Vernon Murenje, Batsirai Makunike-Chikwinya, Marrianne Holec, Sinokuthemba Xaba, Shirish Balachandra, John Mandisarisa, Vuyelwa Sidile-Chitimbire, Scott Barnhart and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Caryl FeldackerInternational Training and Education Center for Health (I-TECH), Seattle, Washington, United States of America.ORCID 0000-0002-8152-6754
Aaron F BochnerInternational Training and Education Center for Health (I-TECH), Seattle, Washington, United States of America.
Vernon MurenjeInternational Training and Education Center for Health (I-TECH), Harare, Zimbabwe.
Batsirai Makunike-ChikwinyaInternational Training and Education Center for Health (I-TECH), Harare, Zimbabwe.
Marrianne HolecInternational Training and Education Center for Health (I-TECH), Seattle, Washington, United States of America.
Sinokuthemba XabaMinistry of Health and Child Care, Harare, Zimbabwe.
Shirish BalachandraU.S. Centers for Disease Control and Prevention, Harare, Zimbabwe.
John MandisarisaU.S. Centers for Disease Control and Prevention, Harare, Zimbabwe.
Vuyelwa Sidile-ChitimbireZimbabwe Association of Church-related Hospitals (ZACH), Harare, Zimbabwe.
Scott BarnhartInternational Training and Education Center for Health (I-TECH), Seattle, Washington, United States of America.
Mufuta TshimangaCommunity Health Intervention Project (ZiCHIRe), Harare, Zimbabwe.
University of Washington · USMinistry of Health and Child Welfare · ZWOffice of the National Coordinator for Health Information Technology · USPractical Action · ZWZimbabwe Association of Church-Related Hospitals · ZW

Funding

CGH CDC HHS U2G GH000972PEPFAR
6 · The paper itself

Abstract

backgroundTiming of routine follow-up visits after adult male circumcision (MC) differs by country and method. Most men do not attend all routine follow-up visits. This cross-sectional study aimed to further understanding of AE timing within a large-scale, routine, MC program to improve patient safety.

methodsFrom 2013-2017, ZAZIC consortium performed 192,575 MCs in Zimbabwe; the reported adverse event (AE) rate was 0.3%. Three scheduled, routine, follow-up visits intend to identify AEs. For surgical MC, visits were days 2, 7 and 42 post-procedure. For PrePex (device-based), visits were days 7, 14 and 49. Descriptive statistics explored characteristics of those patients with AEs. For each MC method, chi-square tests were used to evaluate associations between AE timing (days from MC to AE diagnosis) and factors of interest (age, AE type, severity).

resultsOf 421 AEs, 290 (69%) were surgical clients: 55 (19%) AEs were ≤2 days post-MC; 169 (58%) between 3-7 days; 47 (16%) between days 8-14; and 19 (7%) were ≥15 post-MC. Among surgical clients, bleeding was most common AE on/before Day 2 while infections predominated in other follow-up periods (p<0.001). Younger surgical MC patients with AEs experienced AEs later than older clients (p<0.001). Among 131 (31%) PrePex clients with AEs, 46 (35%) were ≤2 days post-MC; 59 (45%) between 3-7 days; 16 (12%) between days 8-14; and 10 (7%) ≥15 post-MC. For PrePex clients, device displacements were more likely to occur early while late AEs were most commonly infections (p<0.001).

conclusionAlmost 23% of surgical and 8% of PrePex AEs occurred after Visit 2. Later AEs were likely infections. Clinicians, clients, and caregivers should be more effectively counseled that complications may arise after initial visits. Messages emphasizing attention to wound care until complete healing could help ensure client safety. Younger boys, ages 10-14, and their caregivers would benefit from improved, targeted, post-operative counseling.

Indexed as

AdolescentAdultAftercareChildCircumcision, MaleCommunity Health ServicesCross-Sectional StudiesDelivery of Health CareHumansMalePostoperative HemorrhageSurgical InstrumentsSurgical Wound InfectionTime FactorsYoung AdultZimbabwe

Identifiers

PMID30192816
PMCPMC6128519
OpenAlexW2891597983

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.